The Current Status of Generic GLP-1 Drugs At present, fully interchangeable generic alternatives to GLP-1 medications remain limited in major markets like the United States
Annals of Internal Medicine, 119(10), 1029-1035
Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats
Furthermore, studies have shown that this potentiation is due to the perturbation of the bacterial outer membrane and the upregulation of stress response sensors 138
Some GLP-1R agonists, such as Altimmunes pemvidutide, can cause GI-related discontinuation rates as high as 12% (within 16 weeks)
The trial that took place over 72 weeks involved 938 patients with type 2 diabetes who were overweight or obese, drugmaker Eli Lilly said in a press release on Thursday